Search

everythinglearnresearchcommunity

for

Search:↓

Creatine monohydrate is safe and effective for muscle recovery and performance, especially for those with low creatine levels.

Low-dose oral minoxidil may help with hair loss, but more research is needed.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

Topical thyroid hormones may boost hair growth.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Applying thyroid hormones to the scalp can help hair grow.

Iron is essential for many body functions, and its deficiency causes serious health problems.

CYLD deficiency in skin tumors disrupts hair follicle cell processes and protein secretion.

KAP-depleted hair causes less immune response and is more biocompatible for implants.

Different types of resting melanocyte stem cells have unique characteristics and vary in their potential to become other cells.

Melanocytes are important for normal body functions and have potential uses in regenerative medicine and disease treatment.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Men can also experience patterns of hair loss typically seen in women.

Flibanserin shows promise for treating male sexual dysfunction but has side effects like insomnia and fatigue.

The research found that genetic factors for male pattern baldness in African men differ significantly from those in Europeans.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

Different types of inactive melanocyte stem cells exist with unique characteristics and potential to develop into other cells.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Immune cells are essential for early hair and skin development and healing.

Talquetamab may cause hair loss and skin issues.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

Male pattern hair loss may be linked to the developmental origins of hair follicles.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Estrogen may help improve COVID-19 outcomes, especially in women.